Becton, Dickinson and (BDXB) Stock Analysis

What Becton, Dickinson and does

Becton, Dickinson and Company (BD) is a leading global medical technology enterprise. It designs, produces, and distributes a comprehensive portfolio of medical supplies, devices, laboratory instruments, and diagnostic solutions. Its diverse customer base spans healthcare institutions, medical professionals, life science researchers, clinical laboratories, the pharmaceutical industry, and consumers worldwide. The BD Medical segment concentrates on medication management and patient care. This division delivers a broad spectrum of products, including advanced IV and catheter systems (e.g., peripheral, central, dialysis), vascular access tools, and a variety of syringes and needles for general injection, anesthesia, and diabetes care. It also provides comprehensive solutions for medication preparation and administration, such as infusion therapy systems, automated dispensing units, and inventory tracking software, along with specialized prefillable drug delivery systems. The BD Life Sciences segment is dedicated to diagnostics and research. It supplies essential products for specimen and blood collection, along with advanced diagnostic systems covering automated blood and tuberculosis culturing, molecular testing, microorganism identification, drug susceptibility analysis, and liquid-based cytology. Furthermore, this segment provides rapid diagnostic assays, microbiology automation tools, and plated media. For cellular research and specialized clinical diagnostics, it offers fluorescence-activated cell sorters and analyzers, antibodies, reagent kits, and solutions for single-cell gene expression, oncology, immunology, and transplantation monitoring. BD Interventional provides a comprehensive portfolio for surgical and specialized interventional procedures. This encompasses products for hernia and soft tissue repair, a variety of biological and bioresorbable grafts, and biosurgery solutions. The segment also offers tools for surgical infection prevention, surgical and laparoscopic instrumentation, products for peripheral vascular intervention, and essential urology and critical care items. Established in 1897, the company maintains its headquarters in Franklin Lakes, New Jersey.

Key metrics

ETFs linked to BDXB

Broad-market and Healthcare sector ETFs an investor holding Becton, Dickinson and is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how BDXB fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Becton, Dickinson and?

Becton, Dickinson and trades under the ticker BDXB on NYSE.

Which exchange is BDXB listed on?

BDXB is listed on NYSE.

What sector does Becton, Dickinson and operate in?

Becton, Dickinson and is classified in the Healthcare sector (Medical - Instruments & Supplies industry).

How can PortView help analyze BDXB in a portfolio?

PortView shows BDXB's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.